Cyclooxygenase‐2 in gastrointestinal malignancies
نویسندگان
چکیده
منابع مشابه
Disease Biomarkers in Gastrointestinal Malignancies
1Department of Surgery, University of Alabama, Birmingham, AL 35233, USA 2Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada M5G 2M9 3Department of Surgery, Drexel University, Philadelphia, PA 19102, USA 4Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad 91967, Iran 5Department of Surgery, Massachusetts General Hospital, Boston, MA 02114...
متن کاملChemotherapy of Gastrointestinal Malignancies.
Beginning with esophageal cancer of both the adeno and squamous variety, it would appear that combined modality therapy is here to stay. Most cancer programs now advocate chemotherapy, usually cisplatin and 5-fluorouracil together with radiation therapy, prior to definitive esophagectomy for localized disease. An exciting advance is the discovery of the activity of paclitaxel in this setting, a...
متن کاملImmunotherapy for gastrointestinal malignancies.
BACKGROUND Gastrointestinal (GI) cancers are the most common human tumors encountered worldwide. The majority of GI cancers are unresectable at the time of diagnosis, and in the subset of patients undergoing resection, few are cured. There is only a modest improvement in survival with the addition of modalities such as chemotherapy and radiation therapy. Due to an increasing global cancer burde...
متن کاملCisplatin and irinotecan in upper gastrointestinal malignancies.
Irinotecan (CPT-11, Camptosar) a topoisomerase I inhibitor derived from the Chinese shrub Camptotheca acuminata, has broad activity in varied gastrointestinal malignancies, including pancreatic, biliary, esophageal, and stomach cancers. Using cisplatin (Platinol) plus irinotecan as a backbone for chemotherapy, a combination for which in vitro synergy and possible sequence dependency have been i...
متن کاملIrinotecan and cisplatin in upper gastrointestinal malignancies.
Irinotecan (CPT-11 [Camptosar]), an active agent in the treatment of fluorouacil-refractory colorectal cancer, has antitumor activity in upper gastrointestinal cancers. Clinical trials from Japan indicate antitumor responses in gastric and pancreatic cancers. Cisplatin (Platinol), a central agent in the treatment of upper gastrointestinal malignancies, is a logical drug to study in combination ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 2019
ISSN: 0008-543X,1097-0142
DOI: 10.1002/cncr.32010